Synergenics Home

Companies

Numera
Advanced personal health management system for improving the health of populations.  Real time data capture from virtually any electronic home monitoring/metric device; provides Internet and mobile access to a secure, interactive and shareable record for individuals, health professionals, payers and other healthcare companies (aggregated and anonymous data.)  Emphasis on health maintenance and chronic condition management. Global markets.

Relia Diagnostic Systems
Rapid, sensitive and quantitative point-of-care diagnostics for infectious disease, cardiac disease and a variety of other indications suitable for the POC market.

Ventria Bioscience
Cost-effective production of human proteins in cereal grains/rice. Products for antibody/protein production market, and orally active human therapeutic proteins.

Synco Bio Partners
Development and moderate scale GMP manufacturing of Therapeutic proteins, antibodies and vaccines.

Humabs
Human monoclonal antibodies isolated from cloned human memory B cells selected for activity against infectious diseases, cancer and certain other debilitating diseases.

Pathologica
Small molecule drugs that target a defined class of inflammatory macrophages involved in production of cytokines , and etiology of a wide range of pathologies.

BioEnergenix
Drug development involving a novel therapeutic target controlling obesity and diabetes.

 

 

Numera

Relia

Ventria

SynCo

Humabs

Pathologica

BioEnergenix